University of Limerick
Limerick, Munster, Ireland
NCT Number: NCT01939717
Primary aim is to conduct a pilot trial to determine:
1. The feasibility and efficiency of randomisation procedures and study design 2. If recruitment rates are sufficient to adequately power a larger trial
The secondary aim is to determine the efficiency of set dancing in comparison to a control for people with Patkinson's disease.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Limerick, Munster, Ireland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will attend ten weeks of set dancing classes. Each class will be one and half hours. Family members will be invited to partner each participant with Parkinson's disease during the class. Set dancing steps and sets will be thought and progressed in line with the participants abilities. Frequent rests will be taken during the classes.
Participants will be given a home exercise programme which will involve chair based exercises, mental rehearsal, listening music, watching a dance DVD and practicing dance material thought in class.
Time frame: This outcome measure will be assessed over a 1 year period from study inception to completion
Time frame: This outcome measure will be assessed over a 1 year period from study inception to completion
Attrition rate of ≤ 20% per group will be deemed acceptable
Time frame: This outcome will be assessed during the 10 week set dancing intervention
Time frame: This outcome will be assessed over a one year recruitment period
Recruitment considered successful and feasible is 100 participants are recruited in one year
Time frame: This outcome measure will be assessed over a 1 year period from study inception to completion
Document issues regarding availability of personnel or buildings needed to implement study methodology
Time frame: This outcome will be assessed the week after the intervention period ends.
The exit questionnaire will assess participants' satisfaction with the dance intervention at the end of the study. The questionnaire asks participants if they have noted improvements in different aspects of physical well-being, and allows feedback relating to the structure, material and enjoyment of the dance classes to be gathered. This questionnaire has previously been used in other studies investigating the benefit of dance for those with Parkinson's disease (Hackney and Earhart 2009; Hackney and Earhart 2010).
Time frame: This outcome will be assessed within a week before the intervention begins and within a week after the intervention period ends
Self-report quality of life questionnaire
Time frame: This outcome will be assessed within a week before the intervention begins and within a week after the intervention period ends
Disease specific measure of motor function
Time frame: This outcome will be assessed within a week before the intervention begins and within a week after the intervention period ends
Measure of functional endurance
Time frame: This outcome will be assessed within a week before the intervention begins and within a week after the intervention period ends
Balance measure
University of Limerick
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03648905
Autonomic Failure, Autonomic Nervous System Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT01621581
Basal Ganglia Diseases, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT05699460
Autonomic Nervous System Diseases, Basal Ganglia Diseases
Irvine, California, United States
View Trial DetailsNCT07720869
Basal Ganglia Diseases, Brain Diseases
Baton Rouge, Louisiana, United States
View Trial Details